Compare LEXX & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | MGRX |
|---|---|---|
| Founded | 2004 | 2021 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 15.6M |
| IPO Year | N/A | 2023 |
| Metric | LEXX | MGRX |
|---|---|---|
| Price | $0.70 | $0.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 01-13-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $705,923.00 | $466,908.00 |
| Revenue This Year | $13.35 | N/A |
| Revenue Next Year | $78.83 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 52.05 | N/A |
| 52 Week Low | $0.46 | $0.52 |
| 52 Week High | $2.43 | $6.15 |
| Indicator | LEXX | MGRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.39 | 43.36 |
| Support Level | $0.46 | $0.65 |
| Resistance Level | $0.72 | $0.90 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 58.20 | 39.44 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.